How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

634 results for

Chronic Fatty Diarrhea

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. Chronic Fatty Diarrhea

Chronic Fatty Diarrhea Chronic Fatty Diarrhea Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Chronic Fatty Diarrhea Chronic Fatty (...) Diarrhea Aka: Chronic Fatty Diarrhea , Diarrhea due to Malabsorption From Related Chapters II. Causes: Malabsorption or altered digestion Carbohydrate malabsorption (e.g. lactose intollerance) ( ) Whipple's Disease (Tropheryma whipplei infection) Short bowel syndrome Superior insufficiency Pancreatic insufficiency Bile acid inadequate in bowel Non-invasive infection l overgrowth (>100,000 /ml) Tropical sprue III. Symptoms Pale, bulky stools Frothy or greasy stools Foul odor to stool Weight loss

2018 FP Notebook

2. Advances in Evaluation of Chronic Diarrhea in Infants (PubMed)

Advances in Evaluation of Chronic Diarrhea in Infants Diarrhea is common in infants (children less than 2 years of age), usually acute, and, if chronic, commonly caused by allergies and occasionally by infectious agents. Congenital diarrheas and enteropathies (CODEs) are rare causes of devastating chronic diarrhea in infants. Evaluation of CODEs is a lengthy process and infrequently leads to a clear diagnosis. However, genomic analyses and the development of model systems have increased our (...) understanding of CODE pathogenesis. With these advances, a new diagnostic approach is needed. We propose a revised approach to determine causes of diarrhea in infants, including CODEs, based on stool analysis, histologic features, responses to dietary modifications, and genetic tests. After exclusion of common causes of diarrhea in infants, the evaluation proceeds through analyses of stool characteristics (watery, fatty, or bloody) and histologic features, such as the villus to crypt ratio in intestinal

Full Text available with Trip Pro

2018 Gastroenterology

3. An Audit on Management of Chronic Diarrhea

with abdominal pain with or without elevated levels of inflammatory markers. Malabsorption syndrome e.g Celiac disease,cystic fibrosis where the stools are usually fatty in nature and bulky in amount. Good management of chronic diarrhea must include investigations and treatment.A protocol must be followed accurately therefore. Methodology: measurment of the degree of sticking of staff in Gastro-enterology unit to the agreed upon unit's protocol in management of chronic diarrhea over the period of one year (...) An Audit on Management of Chronic Diarrhea An Audit on Management of Chronic Diarrhea - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. An Audit on Management of Chronic Diarrhea (AAOMOCD) The safety

2017 Clinical Trials

4. Comparison of the systemic phospholipid profile in dogs diagnosed with idiopathic inflammatory bowel disease or food-responsive diarrhea before and after treatment. (PubMed)

Comparison of the systemic phospholipid profile in dogs diagnosed with idiopathic inflammatory bowel disease or food-responsive diarrhea before and after treatment. Inflammatory bowel disease (IBD) and food-responsive diarrhea (FRD) are common chronic enteropathies in dogs, of which the exact pathogenesis has not been fully understood. In people dyslipidemia has been reported in patients with IBD, and potential therapeutic benefits of polyunsaturated fatty acids (PUFA) in the treatment of IBD

Full Text available with Trip Pro

2019 PLoS ONE

5. Mechanisms of Preventing Antibiotic-Associated Diarrhea and the Role for Probiotics (R61)

effects of antibiotic medications. One of the most common indications for probiotics is for prevention of antibiotic-associated diarrhea. Clinically, different probiotic strains have demonstrated the ability to prevent AAD; however, the mechanism of action behind this effect has not been elucidated. Data from several studies suggest that antibiotic-induced disruption of commensal bacteria in the colon results in a significant (up to 50%) reduction in short chain fatty acid (SCFA) production (...) of the study product Has telephone access Exclusion Criteria: Any chronic condition, such as diabetes or asthma, that requires medication Allergy to strawberry Active diarrhea (three or more loose stools per day for two consecutive days) Any gastrointestinal medications, i.e. medicines for irritable bowel syndrome, gastroesophageal reflux disease, inflammatory bowel disease, etc. (a full medication list will be reviewed by the PIs prior to enrollment) History of heart disease, including valvulopathies

2018 Clinical Trials

6. Chronic Fatty Diarrhea

Chronic Fatty Diarrhea Chronic Fatty Diarrhea Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Chronic Fatty Diarrhea Chronic Fatty (...) Diarrhea Aka: Chronic Fatty Diarrhea , Diarrhea due to Malabsorption From Related Chapters II. Causes: Malabsorption or altered digestion Carbohydrate malabsorption (e.g. lactose intollerance) ( ) Whipple's Disease (Tropheryma whipplei infection) Short bowel syndrome Superior insufficiency Pancreatic insufficiency Bile acid inadequate in bowel Non-invasive infection l overgrowth (>100,000 /ml) Tropical sprue III. Symptoms Pale, bulky stools Frothy or greasy stools Foul odor to stool Weight loss

2015 FP Notebook

7. Global Vascular Guidelines for patients with chronic limb-threatening ischemia

Global Vascular Guidelines for patients with chronic limb-threatening ischemia Global vascular guidelines on the management of chronic limb-threatening ischemia - Journal of Vascular Surgery Email/Username: Password: Remember me Search JVS Journals Search Terms Search within Search Access provided by Volume 69, Issue 6, Supplement, Pages 3S–125S.e40 Global vascular guidelines on the management of chronic limb-threatening ischemia x Michael S. Conte Affiliations Division of Vascular (...) –938 ---- | ---- Fig 3.1 Flow diagram for the investigation of patients presenting with suspected chronic limb-threatening ischemia (CLTI). ABI, Ankle-brachial index; PAD, peripheral artery disease; TBI, toe-brachial index; WIfI, Wound, Ischemia, and foot Infection. ---- | ---- Fig 3.2 Suggested algorithm for anatomic imaging in patients with chronic limb-threatening ischemia ( CLTI ) who are candidates for revascularization. In some cases, it may be appropriate to proceed directly to angiographic

Full Text available with Trip Pro

2019 Society for Vascular Surgery

8. Gastro 2013 APDW/WCOG Shanghai working party report: chronic diarrhea: definition, classification, diagnosis. (PubMed)

likely to be due to infection; duration of 1 month seems to work well as a cut-off for chronic diarrhea, but detailed scientific knowledge is missing about the utility of this definition. In addition to duration of diarrhea, classifications by presenting scenario, by pathophysiology, and by stool characteristics (e.g. watery, fatty, or inflammatory) may help the canny clinician refine the differential diagnosis of chronic diarrhea. In this regard, a careful history remains the essential part (...) Gastro 2013 APDW/WCOG Shanghai working party report: chronic diarrhea: definition, classification, diagnosis. Diarrhea is best defined as passage of loose stools often with more frequent bowel movements. For clinical purposes, the Bristol Stool Form Scale works well to distinguish stool form and to identify loose stools. Laboratory testing of stool consistency has lagged behind. Acute diarrhea is likely to be due to infection and to be self-limited. As diarrhea becomes chronic, it is less

Full Text available with Trip Pro

2014 Journal of gastroenterology and hepatology

9. Effects of Dietary Sodium and Potassium Intake on Chronic Disease Outcomes and Risks

Effects of Dietary Sodium and Potassium Intake on Chronic Disease Outcomes and Risks Comparative Effectiveness Review Number 206 Sodium and Potassium Intake: Effects on Chronic Disease Outcomes and Risk s eComparative Effectiveness Review Number 206 Sodium and Potassium Intake: Effects on Chronic Disease Outcomes and Risks Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 5600 Fishers Lane Rockville, MD 20857 www.ahrq.gov Contract No. 290-2015 (...) the methodology and findings will be found on the Effective Health Care Program Web site at www.effectivehealthcare.ahrq.gov. Search on the title of the report. Persons using assistive technology may not be able to fully access information in this report. For assistance contact epc@ahrq.hhs.gov. Suggested citation: Newberry SJ, Chung M, Anderson CAM, Chen C, Fu Z, Tang A, Zhao N, Booth M, Marks J, Hollands S, Motala A, Larkin JK, Shanman R, Hempel S. Sodium and Potassium Intake: Effects on Chronic Disease

2018 Effective Health Care Program (AHRQ)

10. Sodium and Potassium Intake: Effects on Chronic Disease Outcomes and Risks

Sodium and Potassium Intake: Effects on Chronic Disease Outcomes and Risks Comparative Effectiveness Review Number 206 Sodium and Potassium Intake: Effects on Chronic Disease Outcomes and Risk s eComparative Effectiveness Review Number 206 Sodium and Potassium Intake: Effects on Chronic Disease Outcomes and Risks Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 5600 Fishers Lane Rockville, MD 20857 www.ahrq.gov Contract No. 290-2015-00010-I (...) the methodology and findings will be found on the Effective Health Care Program Web site at www.effectivehealthcare.ahrq.gov. Search on the title of the report. Persons using assistive technology may not be able to fully access information in this report. For assistance contact epc@ahrq.hhs.gov. Suggested citation: Newberry SJ, Chung M, Anderson CAM, Chen C, Fu Z, Tang A, Zhao N, Booth M, Marks J, Hollands S, Motala A, Larkin JK, Shanman R, Hempel S. Sodium and Potassium Intake: Effects on Chronic Disease

2018 Effective Health Care Program (AHRQ)

11. Effect of a Fresh Fermented Dairy Drink Product Consumption on Antibiotic Associated Diarrhea and Gastro-Intestinal Disorders

abuse Subjects having diarrhea within the preceding 4-weeks Subjects with severe life-threatening illness, severe evolutive or chronic pathology Immune-suppressed subjects Subjects with benign peptic ulcer or pre-malignant or malignant lesion Subjects presenting with an infection of the gastrointestinal tract Subjects with any past severe gastro-intestinal or metabolic pathology Subjects with history of Helicobacter pylori eradication therapy Subjects with history of cardiac or renal clinically (...) Effect of a Fresh Fermented Dairy Drink Product Consumption on Antibiotic Associated Diarrhea and Gastro-Intestinal Disorders Effect of a Fresh Fermented Dairy Drink Product Consumption on Antibiotic Associated Diarrhea and Gastro-Intestinal Disorders - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached

2016 Clinical Trials

12. OMega-3 Fatty Acid for the Immune Modulation of Colon Cancer

OMega-3 Fatty Acid for the Immune Modulation of Colon Cancer OMega-3 Fatty Acid for the Immune Modulation of Colon Cancer - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. OMega-3 Fatty Acid for the Immune (...) Collaborator: Harvard School of Public Health Information provided by (Responsible Party): Mingyang Song, Massachusetts General Hospital Study Details Study Description Go to Brief Summary: This is a prospective, double-blind, placebo-controlled, stratified, randomized clinical trial to assess the effects of daily 4-gram marine omega-3 polyunsaturated fatty acid (MO3PUFA), through treatment with AMR101 (VASCEPA, icosapent ethyl) on the tumor immune microenvironment and gut microbiome in patients who

2018 Clinical Trials

13. Effect of Fish Oil Enriched In Omega-11 Fatty Acid On Lipoprotein Metabolism In Adults

and cirrhosis) Subjects with chronic diarrhea, gastric bypass or lap-band procedures, ostomies, bowel motility problems, or other conditions that could affect intestinal fat absorption Subjects with any acute and life-threatening condition, such as prior sudden cardiac arrest, acute myocardial infarction (last three months), stroke, embolism Liver enzymes (AST or ALT) levels above 3x upper limit of normal Subjects with a TSH greater than 1.5xULN or clinical evidence of hypo or hyperthyroidism Subjects (...) Effect of Fish Oil Enriched In Omega-11 Fatty Acid On Lipoprotein Metabolism In Adults Effect of Fish Oil Enriched In Omega-11 Fatty Acid On Lipoprotein Metabolism In Adults - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies

2017 Clinical Trials

14. Effects of Short-chain Fatty Acids on Inflammatory and Metabolic Parameters in Maintenance Hemodialysis

Effects of Short-chain Fatty Acids on Inflammatory and Metabolic Parameters in Maintenance Hemodialysis Effects of Short-chain Fatty Acids on Inflammatory and Metabolic Parameters in Maintenance Hemodialysis - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100 (...) ). Please remove one or more studies before adding more. Effects of Short-chain Fatty Acids on Inflammatory and Metabolic Parameters in Maintenance Hemodialysis (PLAN) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02976688 Recruitment Status : Unknown Verified November 2016 by Dr Biagio Di Iorio

2016 Clinical Trials

15. Fecal Bile Acids, Fecal Short Chain Fatty Acids and the Intestinal Microbioita in Patients With IBS and Control Volunteers

Fecal Bile Acids, Fecal Short Chain Fatty Acids and the Intestinal Microbioita in Patients With IBS and Control Volunteers Fecal Metabolome and the Intestinal Microbiota in Irritable Bowel Syndrome - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove (...) Posted : December 5, 2016 Last Update Posted : March 1, 2019 See Sponsor: Indiana University Information provided by (Responsible Party): Andrea Shin, Indiana University Study Details Study Description Go to Brief Summary: The purpose of this study is to find out the relationship between the bile acids, fatty acids (fatty acids are part of the diet) and bacteria that are present in the intestines. Condition or disease Intervention/treatment IBS Radiation: X-Ray Detailed Description: There is emerging

2016 Clinical Trials

16. Aramchol for HIV-associated Nonalcoholic Fatty Liver Disease and Lipodystrophy

to peptic ulcer disease, gastroesophageal reflux, dyspepsia, gastroparesis, chronic diarrhea, chromic constipation, gall bladder disease,pancreatitis, lactose intolerance and celiac disease.Patients who have used anticholinergic or other drugs known to affect gastrointestinal motility within 7 days prior to dosing and throughout the study will also be excluded 17. Patients with hypersensitivity to Aramchol or to any of the excipients in the tablets or with hypersensitivity to cholic acid or bile acid (...) Aramchol for HIV-associated Nonalcoholic Fatty Liver Disease and Lipodystrophy Aramchol for HIV-associated Nonalcoholic Fatty Liver Disease and Lipodystrophy - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more

2016 Clinical Trials

17. Low linolenic and linoleic acid consumption are associated with chronic kidney disease in patients with type 2 diabetes. (PubMed)

as follows: body mass index >40 kg/m2, heart failure, gastroparesis, diabetic diarrhea, dietary counseling by a registered dietitian during the previous 12 months, and inability to perform the weighed diet records (WDR). The dietary fatty acids (saturated, monounsaturated and polyunsaturated) consumption was estimated by 3-day WDR. Compliance with the WDR technique was assessed by comparison of protein intake estimated from the 3-day WDR and from the 24-h urinary nitrogen output performed on the third (...) , cardiovascular disease, ACE inhibitors and/or angiotensin receptor blocker use, systolic blood pressure, fasting plasma glucose and HDL cholesterol. In a separate model, similar results were observed for linoleic acid, adjusting to the same co-variables (OR = 0.95; 95% CI 0.91-0.99; P = 0.006).The lower intake of polyunsaturated fatty acids, especially linolenic and linoleic acid, is associated with chronic kidney disease in patients with type 2 diabetes.

Full Text available with Trip Pro

2018 PLoS ONE

18. The Fecal Microbiome in Cats with Diarrhea (PubMed)

, and Roseburia were significantly increased in healthy cats. Phylum Bacteroidetes was significantly decreased in cats with chronic diarrhea (>21 days duration), while the class Erysipelotrichi and the genus Lactobacillus were significantly decreased in cats with acute diarrhea. The observed changes in bacterial groups were accompanied by significant differences in functional gene contents: metabolism of fatty acids, biosynthesis of glycosphingolipids, metabolism of biotin, metabolism of tryptophan (...) The Fecal Microbiome in Cats with Diarrhea Recent studies have revealed that microbes play an important role in the pathogenesis of gastrointestinal (GI) diseases in various animal species, but only limited data is available about the microbiome in cats with GI disease. The aim of this study was to evaluate the fecal microbiome in cats with diarrhea. Fecal samples were obtained from healthy cats (n = 21) and cats with acute (n = 19) or chronic diarrhea (n = 29) and analyzed by sequencing of 16S

Full Text available with Trip Pro

2015 PloS one

19. Clinical Trial to Evaluate the Effect of Raltegravir Intensification (1.200 mg QD) on the Gut Microbiota of Chronically HIV-1 Infected Subject Over Time: THE RAGTIME STUDY

bowel resection at any time. 6.3. Any chronic digestive disease such as peptic ulcer, Crohn's disease, ulcerative colitis, coeliac disease, confirmed intolerance to lactose or indeterminate colitis. 6.4. Persistent infectious gastroenteritis, colitis or gastritis; persistent or chronic diarrhea of unknown etiology; Clostridium difficile infection (recurrent) or Helicobacter pylori infection (untreated) 6.5. Irritable bowel syndrome (moderate-severe) 6.6. Chronic constipation 6.7. Active proctitis (...) Clinical Trial to Evaluate the Effect of Raltegravir Intensification (1.200 mg QD) on the Gut Microbiota of Chronically HIV-1 Infected Subject Over Time: THE RAGTIME STUDY Clinical Trial to Evaluate the Effect of Raltegravir Intensification (1.200 mg QD) on the Gut Microbiota of Chronically HIV-1 Infected Subject Over Time: THE RAGTIME STUDY - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search

2017 Clinical Trials

20. Effects of Resistant Starch Diet on the Gut Microbiome in Chronic Kidney Disease

Effects of Resistant Starch Diet on the Gut Microbiome in Chronic Kidney Disease Effects of Resistant Starch Diet on the Gut Microbiome in Chronic Kidney Disease - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding (...) more. Effects of Resistant Starch Diet on the Gut Microbiome in Chronic Kidney Disease The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03356990 Recruitment Status : Recruiting First Posted : November 29, 2017 Last Update

2017 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>